The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy-Reference-Cited by-同舟云学术

The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy

Published:2022-12 Issue:5 Volume:114 Page:989-999
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Barry Aisling S.^ORCID,Bezjak Andrea,Helou Joelle,Goodwin Pamela,Kiss Alex,Ringash Jolie,Goody Rebecca,Munoz-Schuffenegger Pablo,Lindsay Patricia E.,Pellizzari Alana,Ponichtera Jan,Liu Zhi Hui,Wong Rebecca

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. SBRT: An opportunity to improve quality of life for oligometastatic prostate cancer;Azzam;Front Oncol,2015

2. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial;Palma;Lancet,2019

3. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study;Gomez;J Clin Oncol,2019

4. The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “real-world”: Results from the population-based PROFILES registry;Husson;Oncologist,2020

5. Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy;Coates;Eur J Cancer,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions;Current Oncology Reports;2024-04-23

2. Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial;Clinical Oncology;2024-03

3. Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial;Clinical Oncology;2023-12